Skip to content

Brain Works

Facebook
Twitter
LinkedIn
Ariana Gatt talks about pharma, fruit fly research, and Alzheimer’s and Parkinson’s disease.
Ariana Gatt
Ariana Gatt

In 2008 I graduated from the University of Malta with a B.Sc. in Chemistry and Biology. Then, I worked as an R&D chemist with SoleaPharma Ltd., which also allowed me to spend six months training in pharmaceutical chemistry in Spain at the mother company Gadea Pharmaceuticals. I learned a lot in this period—not only lab work skills, but also about the whole business and industry. However, after two years working in the pharma industry, I realised I still wanted to further my studies.

I had always dreamed of studying abroad and experiencing a university in another country, so I applied for Masters courses in the UK. I had realised by this point that I wanted to carry out biomedical research, with a particular interest in neuroscience. I read for an M.Sc. in molecular sciences and biomedical research at King’s College London, funded by an EU funded STEPS scholarship. The M.Sc. opened the door for a Ph.D. in the same lab, which I am currently finishing .

For my Ph.D., I am investigating the role of mitochondrial dysfunction in neurodegeneration. Mitochondria produce energy for our cells. They are especially important in brain cells, since the brain uses 20% of the body’s energy. In neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, mitochondria stop functioning properly, leading to a loss of energy in the brain. This may contribute to the eventual death of brain cells. In my project, I am modelling the loss of mitochondrial function in fruit flies (Drosophila melanogaster) to understand the early stages of neurodegeneration. Fruit flies and humans share many genes and therefore, studying the genes involved in mitochondrial dysfunction in the fly allows us to find potential early treatments to prevent irreparable damage in human neurodegenerative diseases. 

Part of my Ph.D. focuses on studying human tissue from patients who have died from these diseases. These post-mortem tissue samples are obtained from UK brain banks. I am using them to identify genes that are involved in these diseases. 

I don’t know what lies ahead in my career path. I hope it will involve answering questions regarding brain function and helping to solve the many puzzles related to neurodegenerative disease. 

Author

More to Explore

INNOVATION

‘Fun, exciting and challenging’ is how Federica, NOVA logistics officer, described her undergraduate experience with UM’s Department of Digital Arts. Now in their final year, the Bachelor of Fine Arts cohort, guided by Dr Trevor Borg, is dotting all the i’s and crossing all their t’s in preparation for their thesis exhibition. THINK took the opportunity to talk with a few members of the logistics team to learn what NOVA is all about.

Exploring Additional Functionality for Home Battery Storage Systems

Using renewable energy, like solar photovoltaic, to generate electricity for direct use and to electrify other sectors significantly reduces greenhouse gas emissions. Yet, the intermittent nature and dependence on solar irradiation – the amount of energy the sun puts out at a time – complicate the operation of the power network. Home battery storage systems can assist in multiple ways.

Unlocking Knowledge: The Power of Open Access to Research Data

Research Data Management offers researchers a way to safeguard their findings and a pathway to collaboration, efficiency, and greater recognition for their work. At its core, research data forms the foundation of every scholarly discovery, making Open Access essential for more transparent and reusable research.

Comments are closed for this article!